APA (7th ed.) Citation

Kastritis, E., Palladini, G., Minnema, M. C., Wechalekar, A. D., Jaccard, A., Lee, H. C., . . . Comenzo, R. L. (2021). Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. The New England journal of medicine, 385(1), . https://doi.org/10.1056/NEJMoa2028631

Chicago Style (17th ed.) Citation

Kastritis, Efstathios, et al. "Daratumumab-based Treatment for Immunoglobulin Light-chain Amyloidosis." The New England Journal of Medicine 385, no. 1 (2021). https://doi.org/10.1056/NEJMoa2028631.

MLA (9th ed.) Citation

Kastritis, Efstathios, et al. "Daratumumab-based Treatment for Immunoglobulin Light-chain Amyloidosis." The New England Journal of Medicine, vol. 385, no. 1, 2021, https://doi.org/10.1056/NEJMoa2028631.